These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 32246378)

  • 1. Frequency of radiation-induced malignancies post-adjuvant radiotherapy for breast cancer in patients with Li-Fraumeni syndrome.
    Le AN; Harton J; Desai H; Powers J; Zelley K; Bradbury AR; Nathanson KL; Shah PD; Doucette A; Freedman GM; Gabriel P; Domchek SM; MacFarland SP; Maxwell KN
    Breast Cancer Res Treat; 2020 May; 181(1):181-188. PubMed ID: 32246378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiotherapy-induced malignancies in breast cancer patients with TP53 pathogenic germline variants (Li-Fraumeni syndrome).
    Petry V; Bonadio RC; Cagnacci AQC; Senna LAL; Campos RDNG; Cotti GC; Hoff PM; Fragoso MCBV; Estevez-Diz MDP
    Fam Cancer; 2020 Jan; 19(1):47-53. PubMed ID: 31748977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation therapy and secondary malignancy in Li-Fraumeni syndrome: A hereditary cancer registry study.
    Hendrickson PG; Luo Y; Kohlmann W; Schiffman J; Maese L; Bishop AJ; Lloyd S; Kokeny KE; Hitchcock YJ; Poppe MM; Gaffney DK; Tao R
    Cancer Med; 2020 Nov; 9(21):7954-7963. PubMed ID: 32931654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of Radiation Therapy-Induced Malignancies in Patients With Li-Fraumeni Syndrome and Early-Stage Breast Cancer and the Influence of Radiation Therapy Technique.
    Petry V; Bonadio RC; Moutinho K; Leite LS; Testa L; Cohn DJBH; Cagnacci AC; Kim VEH; Del Pilar Estevez-Diz M; Fragoso MCBV
    Int J Radiat Oncol Biol Phys; 2024 Jul; 119(4):1086-1091. PubMed ID: 38309330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chest wall leiomyosarcoma after breast-conservative therapy for early-stage breast cancer in a young woman with Li-Fraumeni syndrome.
    Henry E; Villalobos V; Million L; Jensen KC; West R; Ganjoo K; Lebensohn A; Ford JM; Telli ML
    J Natl Compr Canc Netw; 2012 Aug; 10(8):939-42. PubMed ID: 22878818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TP53 germline mutation may affect response to anticancer treatments: analysis of an intensively treated Li-Fraumeni family.
    Kappel S; Janschek E; Wolf B; Rudas M; Teleky B; Jakesz R; Kandioler D
    Breast Cancer Res Treat; 2015 Jun; 151(3):671-8. PubMed ID: 25981898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li-Fraumeni syndrome.
    Heymann S; Delaloge S; Rahal A; Caron O; Frebourg T; Barreau L; Pachet C; Mathieu MC; Marsiglia H; Bourgier C
    Radiat Oncol; 2010 Nov; 5():104. PubMed ID: 21059199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiosarcoma in previously irradiated breast in patient with Li-Fraumeni syndrome. A case report.
    Barbosa OV; Reiriz AB; Boff RA; Oliveira WP; Rossi L
    Sao Paulo Med J; 2015; 133(2):151-3. PubMed ID: 25271877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort.
    Masciari S; Dillon DA; Rath M; Robson M; Weitzel JN; Balmana J; Gruber SB; Ford JM; Euhus D; Lebensohn A; Telli M; Pochebit SM; Lypas G; Garber JE
    Breast Cancer Res Treat; 2012 Jun; 133(3):1125-30. PubMed ID: 22392042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A matched case-control study of the prognosis of early breast cancer in patients with Li-Fraumeni syndrome (BREAST TP53).
    Petry V; Bonadio RC; Testa L; Cohn DJ; Cagnacci A; Campos RG; Fragoso MCB; Estevez-Diz MDP
    Breast; 2023 Apr; 68():157-162. PubMed ID: 36773404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Li-Fraumeni syndrome presenting as mucosal melanoma: Case report and treatment considerations.
    Klein JD; Kupferman ME
    Head Neck; 2017 Feb; 39(2):E20-E22. PubMed ID: 27726232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of late-onset Li-Fraumeni-like syndrome with unilateral breast cancer.
    Cho Y; Kim J; Kim Y; Jeong J; Lee KA
    Ann Lab Med; 2013 May; 33(3):212-6. PubMed ID: 23667851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical guidelines for Li-Fraumeni syndrome 2019, version 1.1.
    Kumamoto T; Yamazaki F; Nakano Y; Tamura C; Tashiro S; Hattori H; Nakagawara A; Tsunematsu Y
    Int J Clin Oncol; 2021 Dec; 26(12):2161-2178. PubMed ID: 34633580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort.
    Mai PL; Best AF; Peters JA; DeCastro RM; Khincha PP; Loud JT; Bremer RC; Rosenberg PS; Savage SA
    Cancer; 2016 Dec; 122(23):3673-3681. PubMed ID: 27496084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between choroid plexus carcinoma and Li-Fraumeni syndrome: implications of TP53 mutations and management strategies-a case-based narrative review.
    Mallik D; Gopal S; Scalia G; Umana G; Rajeswarie RT; Chaurasia B
    Childs Nerv Syst; 2024 Jun; 40(6):1699-1705. PubMed ID: 38316675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical spectrum of Li-Fraumeni syndrome/Li-Fraumeni-like syndrome in Brazilian individuals with the TP53 p.R337H mutation.
    Ferreira AM; Brondani VB; Helena VP; Charchar HLS; Zerbini MCN; Leite LAS; Hoff AO; Latronico AC; Mendonca BB; Diz MDPE; de Almeida MQ; Fragoso MCBV
    J Steroid Biochem Mol Biol; 2019 Jun; 190():250-255. PubMed ID: 30974190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late onset Li-Fraumeni Syndrome with bilateral breast cancer and other malignancies: case report and review of the literature.
    Kast K; Krause M; Schuler M; Friedrich K; Thamm B; Bier A; Distler W; Kr├╝ger S
    BMC Cancer; 2012 Jun; 12():217. PubMed ID: 22672556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematologic malignancies and Li-Fraumeni syndrome.
    Swaminathan M; Bannon SA; Routbort M; Naqvi K; Kadia TM; Takahashi K; Alvarado Y; Ravandi-Kashani F; Patel KP; Champlin R; Kantarjian H; Strong L; DiNardo CD
    Cold Spring Harb Mol Case Stud; 2019 Feb; 5(1):. PubMed ID: 30709875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of Thyroid Carcinoma in Brazilian TP53 p.R337H Carriers With Li Fraumeni Syndrome.
    Formiga MNDC; de Andrade KC; Kowalski LP; Achatz MI
    JAMA Oncol; 2017 Oct; 3(10):1400-1402. PubMed ID: 28114597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.
    Ruijs MW; Verhoef S; Rookus MA; Pruntel R; van der Hout AH; Hogervorst FB; Kluijt I; Sijmons RH; Aalfs CM; Wagner A; Ausems MG; Hoogerbrugge N; van Asperen CJ; Gomez Garcia EB; Meijers-Heijboer H; Ten Kate LP; Menko FH; van 't Veer LJ
    J Med Genet; 2010 Jun; 47(6):421-8. PubMed ID: 20522432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.